A Very Compact Metamaterial-Based Triple-Band Sensor in Terahertz Spectrum as a Perfect Absorber for Human Blood Cancer Diagnostics


Creative Commons License

Hamza M. N., Abdulkarim Y. I., Saeed S. R., Hamad M. A., Muhammadsharif F. F., BAKIR M., ...Daha Fazla

Plasmonics, 2024 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2024
  • Doi Numarası: 10.1007/s11468-024-02291-8
  • Dergi Adı: Plasmonics
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, INSPEC
  • Anahtar Kelimeler: Absorber, Cancer detection, Metamaterial, Sensor, Terahertz
  • Yozgat Bozok Üniversitesi Adresli: Evet

Özet

Nowadays, early cancer identification and surveillance have become vital problems. This research paper explores the development of a small, three-band sensor harnessing the potential of terahertz (THz) technology and metamaterials (MTMs) to diagnose blood cancer. The proposed sensor holds the promise of a paradigm shift in the diagnosis of blood cancer by offering a non-invasive and highly accurate approach. Terahertz radiation, occupying the unique “THz gap” in the electromagnetic spectrum, is now accessible due to recent technological breakthroughs. This work simplifies the design of multiple-band metamaterial absorbers, enhancing their effectiveness and expanding their sensing capabilities. Through the integration of THz technology, metamaterial engineering, and cancer detection, the suggested sensor seeks to launch a new phase of rapid, precise, and non-invasive blood cancer diagnosis. The proposed structure is capable of distinguishing cancer and normal cell with 1 GHz sensitivity, which would be more pronounced when we consider the THz technology devices. This work represents a significant step forward in non-invasive, accurate diagnostics for blood cancer, promising to revolutionize the way this disease is diagnosed and treated. The proposed novel strategy has a lot of promise to advance medical diagnostics and enhance patients’ outcomes.